Click Here to view the Journal of Managed Care Medicine
|
Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.
|
Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.
|
Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!
|
|
|
Personalized genetic testing not recommended
CNN
Share
   
Getting personalized genetic tests that can pinpoint your risk of developing a number of diseases like cancer, diabetes, Alzheimer's or heart disease are not yet "ready for prime time," according to a new recommendation from the American College of Obstetricians and Gynecologists.
More
 |
Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.
|
Gene anomaly can predict behavior of prostate cancer
The Clinical Advisor
Share
The findings of a recent analysis indicate that a specific genomic abnormality found in either benign or malignant prostate tissues is predictive of the clinical outcome of prostate cancer. As researchers state in The American Journal of Pathology, the prediction of prostate cancer clinical outcome remains a major challenge, even with improved early detection by prostate-specific antigen monitoring.
More
Genetic testing may not drive up health costs
MedPage Today
Share
Having the results of a personalized genetic test did not drive patients to utilize potentially costly follow-up healthcare services, a study from the National Institutes of Health found. In the past five years, there have been many new tests marketed to consumers who want to know whether they are genetically susceptible to a range of health conditions and traits, including diabetes and certain types of cancers.
More
| Biotech/Diagnostics/Personalized Medicine |
Hormone replacement therapy, 10 years after cancer link claims
The Washington Post
Share
The use of hormone replacement therapy to treat symptoms of menopause has been among the most controversial and confusing issues in the modern medical world. The July 2012 issue of a journal called Climacteric — the journal of the International Menopause Society — is devoted to revisiting the Women's Health Initiative findings 10 years later and seeks to sort out what turned out to be true and untrue about the therapy's impact on women's health.
More
Study: Trial vaccine made some more vulnerable to HIV
The New York Times
Share
A follow-up study on an AIDS vaccine trial that had to be stopped early has confirmed the worst fears of researchers: The vaccine made it more likely, not less, that some men would become infected with HIV. Men who were not circumcised and who had previously caught common colds caused by the same virus used to make the vaccine were two to four times as likely as other men to become infected if they got the vaccine, the study concluded.
More
|
|
Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. MORE
|
|
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection.
MORE
|
|
Scientists turn skin cells into beating heart muscle
Reuters
Share
Scientists have for the first time succeeded in taking skin cells from patients with heart failure and transforming them into healthy, beating heart tissue that could one day be used to treat the condition. The researchers, based in Haifa, Israel, said there were still many years of testing and refining ahead. But the results meant they might eventually be able to reprogram patients' cells to repair their own damaged hearts.
More
Mechanical properties of stem cells can foretell what they will become
PhysOrg
Share
To become better healers, tissue engineering need a timely and reliable way to obtain enough raw materials: cells that either already are or can become the tissue they need to build. In a new study, Brown University biomedical engineers show the stiffness, viscosity and other mechanical properties of adult stem cells derived from fat, such as liposuction waste, can predict whether they will turn into bone, cartilage or fat.
More
| Emerging Medical Technologies |
A new frontier for wireless medical devices?
American Public Media
Share
 It's only one agenda item at a meeting being held in Washington, D.C. That one item, however, may have an enormous effect on the future of medical treatment. The Federal Communications Commission is scheduled to vote on setting aside part of the broadcast spectrum for wireless medical devices.
More
Inexpensive paper-based diabetes test developed
The Medical News
Share
Scientists have developed a new, inexpensive and easy-to-use urine test for people with type 2 diabetes in areas of extreme poverty, such as rural India, China and other locations in the world. The paper-based device is described in the journal Analytical Chemistry, and could also be adapted to diagnose and monitor other conditions and the environment.
More
Report: For privately insured, doctors, surgery cost more in 2010
The Inquirer
Share
Higher prices for visits to doctors, surgery and drugs were the main cause of higher healthcare costs for privately insured Americans in 2010, when overall utilization of health-care services was down, a report by the Health Care Cost Institute in Washington said.
More
Higher prices charged by hospitals, providers, drove health spending
Kaiser Health News
Share
Higher prices charged by hospitals, outpatient centers and other providers drove up healthcare spending at double the rate of inflation during the economic downturn — even as patients consumed less medical care overall, according to a new study.
More
| FDA: New Treatments and Technology |
Takeda drug impresses in ulcerative colitis study
Reuters
Share
More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical, according to data from a pivotal late-stage trial.
More
FDA reviewer recommends against Pfizer drug
The Wall Street Journal
Share
A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer subsidiary to treat a rare genetic disorder that affects the nervous system because there's "inadequate" evidence the drug works. Pfizer subsidiary FoldRx is seeking FDA approval of a drug called tafamidis to treat an inherited condition called transthyretin familial amyloid polyneuropathy.
More
FAST FACTS
"There are some risks to women undergoing hormone replacement therapy. Researchers have found healthy post-menopausal women were at increased risk of invasive breast cancer, coronary heart disease, stroke and blood clots, according to the National Institutes of Health."
|
|
|
|
Mobile version
